All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-D-1256
Considerations for the use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause; Draft Guidance for Industry; Availability
Documents
2
Comments
40
Description
Open
Key Dates
Comment Period OpensFeb 25, 2026
Comment Period ClosesApr 28, 2026
Documents
Comment Statistics
Total Comments
40
Keywords
CBER
2025-592
Developing Individualized
Therapies Using a Plausible Mechanism Framework
Draft Guidance for Industry; Availability
Data from Regulations.gov